Hans-Peter Gerber

Company: Sutro Biopharma

Job title: Chief Scientific Officer

Seminars:

Novel & Dual Payloads: Assessing Linker Conjugation Technologies That Encourage Flexibility in Payloads 3:50 pm

Evaluating the right ratios, the advantages of releasing drugs in specific ratios, and which combination of drugs make sense when considering dual payloads Discussing the parameters of small molecule degraders and how that lends them to make good payloads Advancing cytoxic or immune-stimulating payloads with novel MoAsRead more

day: Day One P3